Acquisition opportunity Healix Infusion Therapy has been acquired by Singlepoint Healthcare as of June 2026, signaling a shift in ownership and potential integration or expansion needs. Sales teams should position solutions that align with a larger enterprise strategy, such as scalable infusion management software, standardized IT infrastructure, and cross-brand service optimization.

Infusion network growth As a national infusion services provider with physician-owned and ambulatory infusion centers, there is likely ongoing demand for IT modernization, workflow optimization, and data analytics to improve center performance, scheduling, and patient throughput across the network.

Technology stack Current tech usage includes cloud services, LDAP, PHP, and HTTP/3, indicating familiarity with modern web and cloud-based workflows. Opportunities exist to introduce interoperable healthcare IT solutions, security enhancements, and API-driven integrations with existing systems used by infusion centers and partner clinics.

Strategic partnerships history Past collaborations with WeInfuse and DoseMe suggest openness to external software platforms and decision-support tools. This presents a channel for selling integrated software suites such as infusion center workflow platforms, dosing software integrations, and enterprise IT solutions that complement current operations.

Growth and scale fit With revenue in the low single-digit millions and a relatively small employee base, Healix is positioned for scalable, high-impact solutions that improve efficiency and compliance. Target offerings could include cost-effective, modular IT upgrades, remote monitoring services, and standardized training programs for rapid deployment across centers.